Skip to main content
. 2021 Feb 24;12(2):210. doi: 10.1038/s41419-021-03490-5

Fig. 6. miR-6780b-5p promotes EMT in ovarian cancer cells.

Fig. 6

a qRT-PCR was used to compare miR-6780b-5p expression among 18 ADEs with peritoneal metastasis and nine without peritoneal metastasis. ★, #7 ADEs. b Kaplan–Meier analysis of miR-6780b in pancancer analysis with K-M Plotter. c qRT-PCR was used to compare miR-6780b-5p expression in four ovarian cancer cell lines. d qRT-PCR was used to compare the relative miR-6780b-5p expression in four sets of ADEs (#6, #12, #21, #25) from four HGSOC patients. e Western blots of E-cadherin, N-cadherin and Vimentin expression in A2780, CAOV3, ES2, and SKOV3 cells treated with four sets of ADEs with different miR-6780b-5p concentrations. f qPCR validation of the effects of the miR-6780b-5p agomir and antagomir in A2780, CAOV3, ES2, and SKOV3 cells. g Representative images of in vitro wound-healing and transwell migration assays with SKOV3 and ES2 ovarian cancer cells after transfection of miR-6780b-5p stable NC/agomir and inhibitor NC/antagomir. Scale bar for the wound-healing assay, 100 μm. Scale bar for the transwell assay, 100 μm. h The areas of wound closure and the numbers of migrating cells in transwell migration assays were measured and are shown as histograms. i Western blot analysis of the expression of E-cadherin, N-cadherin, and Vimentin in A2780, CAOV3, ES2, and SKOV3 cells after transfection with miR-6780b-5p agomir and antagomir. Experiments were performed in at least triplicate, and the results are shown as the mean ± s.d. values. Student’s t test was used to analyze the data (NS, not significant; *p < 0.05; **p < 0.01; ***p < 0.001).